BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liao Y, Wang C, Yang Z, Liu W, Yuan Y, Li K, Zhang Y, Wang Y, Shi Y, Qiu Y, Zuo D, He W, Qiu J, Guan X, Yuan Y, Li B. Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma. Theranostics 2020;10:5209-24. [PMID: 32373208 DOI: 10.7150/thno.43640] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhang X, Ni Z, Elam E, Thakur K, Li K, Wang C, Zhang J, Wei Z. The anti-cancerous mechanism of licochalcone A on human hepatoma cell HepG2 based on the miRNA omics. Food Science and Human Wellness 2023;12:1136-1148. [DOI: 10.1016/j.fshw.2022.10.039] [Reference Citation Analysis]
2 Zhu H, Zhang Y, Zhu Y. MiR-342-5p protects neurons from cerebral ischemia induced-apoptosis through regulation of Akt/NF-κB pathways by targeting CCAR2. Journal of Stroke and Cerebrovascular Diseases 2023;32:106901. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106901] [Reference Citation Analysis]
3 Beylerli O, Sufianova G, Shumadalova A, Zhang D, Gareev I. MicroRNAs-mediated regulation of glucose transporter (GLUT) expression in glioblastoma. Noncoding RNA Res 2022;7:205-11. [PMID: 36157351 DOI: 10.1016/j.ncrna.2022.09.001] [Reference Citation Analysis]
4 Fan F, Mo H, Zhang H, Dai Z, Wang Z, Qu C, Liu F, Zhang L, Luo P, Zhang J, Liu Z, Cheng Q, Ding F. HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target. Biomedicine & Pharmacotherapy 2022;155:113800. [DOI: 10.1016/j.biopha.2022.113800] [Reference Citation Analysis]
5 Li H, Liu P, Li D, Wang Z, Ding Z, Zhou M, Chen X, Miao M, Ding J, Lin W, Liu Y, Zha X. STAT3/miR-130b-3p/MBNL1 feedback loop regulated by mTORC1 signaling promotes angiogenesis and tumor growth. J Exp Clin Cancer Res 2022;41:297. [PMID: 36217202 DOI: 10.1186/s13046-022-02513-z] [Reference Citation Analysis]
6 Xiong F, Liu W, Wang X, Wu G, Wang Q, Guo T, Huang W, Wang B, Chen Y. HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway. Cell Death Dis 2022;13:829. [DOI: 10.1038/s41419-022-05279-6] [Reference Citation Analysis]
7 Wang J, Guo X, Jiang R, He J, Zhao T, Peng Y, Zheng Y. Research progress in the prevention and treatment of liver fibrosis in Chinese medicine based on miRNAs molecular regulation of angiogenesis. Pharmacological Research - Modern Chinese Medicine 2022;4:100151. [DOI: 10.1016/j.prmcm.2022.100151] [Reference Citation Analysis]
8 Zhou Y, Liu F, Ma C, Cheng Q. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. J Clin Lab Anal 2022;:e24673. [PMID: 36036748 DOI: 10.1002/jcla.24673] [Reference Citation Analysis]
9 Hao F, Wang N, Zhang Y, Xu W, Chen Y, Fei X, Wang J. E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription. Mol Carcinog 2022. [PMID: 35924788 DOI: 10.1002/mc.23454] [Reference Citation Analysis]
10 Cuzziol CI, Marzochi LL, Possebon VS, Kawasaki-oyama RS, Mattos MF, Junior VS, Ferreira LAM, Pavarino ÉC, Castanhole-nunes MMU, Goloni-bertollo EM. Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer. IJMS 2022;23:7483. [DOI: 10.3390/ijms23137483] [Reference Citation Analysis]
11 Zhang Q, Li T, Li Z, Lu J, Wu X, Gao F, Sun W. Autocrine Activity of Extracellular Vesicles Induced by Icariin and Its Effectiveness in Glucocorticoid-Induced Injury of Bone Microvascular Endothelial Cells. Cells 2022;11:1921. [PMID: 35741052 DOI: 10.3390/cells11121921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tong W, Wang G, Zhu L, Bai Y, Liu Z, Yang L, Wu H, Cui T, Zhang Y. Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response. Front Mol Biosci 2022;8:793445. [DOI: 10.3389/fmolb.2021.793445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Wang J, Wei B, Thakur K, Wang CY, Li KX, Wei ZJ. Transcriptome Analysis Reveals the Anti-cancerous Mechanism of Licochalcone A on Human Hepatoma Cell HepG2. Front Nutr 2021;8:807574. [PMID: 34988109 DOI: 10.3389/fnut.2021.807574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen WK, Zhang HJ, Zou MX, Wang C, Yan YG, Zhan XL, Li XL, Wang WJ. LncRNA HOTAIR influences cell proliferation via miR-130b/PTEN/AKT axis in IDD. Cell Cycle 2022;:1-17. [PMID: 34974804 DOI: 10.1080/15384101.2021.2020042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Iloani N, Hafeez A, Bao S, Dulemba V, Lambring C, Sankpal UT, Basha R. Association of specificity protein 1 with hepatocellular carcinoma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 2022. [DOI: 10.1016/b978-0-323-98807-0.00013-2] [Reference Citation Analysis]
16 Cao M, Wang L, Xu D, Bi X, Guo S, Xu Z, Chen L, Zheng D, Li P, Xu J, Zheng S, Wang H, Wang B, Lu J, Li K. The synergistic interaction landscape of chromatin regulators reveals their epigenetic regulation mechanisms across five cancer cell lines. Computational and Structural Biotechnology Journal 2022;20:5028-39. [DOI: 10.1016/j.csbj.2022.09.008] [Reference Citation Analysis]
17 Shi T, Iwama H, Fujita K, Kobara H, Nishiyama N, Fujihara S, Goda Y, Yoneyama H, Morishita A, Tani J, Yamada M, Nakahara M, Takuma K, Masaki T. Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells. Int J Mol Sci 2021;22:13071. [PMID: 34884875 DOI: 10.3390/ijms222313071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Di M, Zhang Y, Zeng R, Liu X, Chen W, Zhang M, Zhang C, Li M, Zhang M. The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs. Int J Biol Sci 2021;17:4122-39. [PMID: 34803487 DOI: 10.7150/ijbs.60302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Sun Y, Lu X, Li H, Li X. Dihydroartemisinin inhibits IL-6-induced epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway. J Int Med Res 2021;49:3000605211009494. [PMID: 34755560 DOI: 10.1177/03000605211009494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
20 Feng Y, Zhang T, Wang Y, Xie M, Ji X, Luo X, Huang W, Xia L. Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention. Front Oncol 2021;11:770428. [PMID: 34722321 DOI: 10.3389/fonc.2021.770428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
21 Deng L, Wang P, Qu Z, Liu N. The Construction and Analysis of ceRNA Network and Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Front Genet 2021;12:667610. [PMID: 34567057 DOI: 10.3389/fgene.2021.667610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
22 Shi Y, Liu Z, Lin Q, Luo Q, Cen Y, Li J, Fang X, Gong C. MiRNAs and Cancer: Key Link in Diagnosis and Therapy. Genes (Basel) 2021;12:1289. [PMID: 34440464 DOI: 10.3390/genes12081289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
23 Wu J, Tang X, Shi Y, Ma C, Zhang H, Zhang J, Lu Y, Wei J, Li L, Han L. β-Elemene suppresses hepatocellular carcinoma cell growth via mediating LncRNA HOTAIR / SP1 / PDK1 axis impact of β-elemene on hepatocellular carcinoma cells growth. J Ethnopharmacol 2021;:114456. [PMID: 34333105 DOI: 10.1016/j.jep.2021.114456] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Jing Y, Gao B, Han Z, Xin S. HOXA5 induces M2 macrophage polarization to attenuate carotid atherosclerosis by activating MED1. IUBMB Life 2021;73:1142-52. [PMID: 34117711 DOI: 10.1002/iub.2515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wu J, Zhang F, Zhang J, Sun Z, Hao C, Cao H, Wang W. A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma. Technol Cancer Res Treat 2021;20:15330338211027923. [PMID: 34159861 DOI: 10.1177/15330338211027923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Zhang Y, Qiu J, Zuo D, Yuan Y, Qiu Y, Qiao L, He W, Li B, Yuan Y. SNRPC promotes hepatocellular carcinoma cell motility by inducing epithelial-mesenchymal transition. FEBS Open Bio 2021;11:1757-70. [PMID: 33934562 DOI: 10.1002/2211-5463.13175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Wang C, Liao Y, He W, Zhang H, Zuo D, Liu W, Yang Z, Qiu J, Yuan Y, Li K, Zhang Y, Wang Y, Shi Y, Qiu Y, Gao S, Yuan Y, Li B. Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma. J Exp Clin Cancer Res 2021;40:113. [PMID: 33771199 DOI: 10.1186/s13046-021-01904-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
28 Bao D, Li M, Zhou D, Zhuang C, Ge Z, Wei Q, Zhang L. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4. J Steroid Biochem Mol Biol 2021;209:105844. [PMID: 33582305 DOI: 10.1016/j.jsbmb.2021.105844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Chen W, Huang L, Liang J, Ye Y, He S, Niu J. Hepatocellular carcinoma cells-derived exosomal microRNA-378b enhances hepatocellular carcinoma angiogenesis. Life Sci 2021;273:119184. [PMID: 33577844 DOI: 10.1016/j.lfs.2021.119184] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
30 Holvoet P. Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer. Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer 2021. [DOI: 10.1007/978-3-030-68844-8_7] [Reference Citation Analysis]
31 Li W, Yan Y, Zheng Z, Zhu Q, Long Q, Sui S, Luo M, Chen M, Li Y, Hua Y, Deng W, Lai R, Li L. Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma. Cell Death Dis 2020;11:1011. [PMID: 33239622 DOI: 10.1038/s41419-020-03218-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Guo Q, Yan J, Song T, Zhong C, Kuang J, Mo Y, Tan J, Li D, Sui Z, Cai K, Zhang J. microRNA-130b-3p Contained in MSC-Derived EVs Promotes Lung Cancer Progression by Regulating the FOXO3/NFE2L2/TXNRD1 Axis. Mol Ther Oncolytics 2021;20:132-46. [PMID: 33575477 DOI: 10.1016/j.omto.2020.09.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
33 Li J, Zheng SJ. Role of MicroRNAs in Host Defense against Infectious Bursal Disease Virus (IBDV) Infection: A Hidden Front Line. Viruses 2020;12:E543. [PMID: 32423052 DOI: 10.3390/v12050543] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]